The results, which were published in the Lancet on Thursday, are very encouraging for the safety and efficacy of orforglipron in people with type 2 diabetes, says Daniel Drucker, an endocrinologist at the University of Toronto, adding that he is awaiting further clinical trial results of the drug in people with obesity
Instead, it depends on the freedom to explore, to fail, and to follow evidence wherever it leads, because that is where the most transformative breakthroughs are often found
C., de Lartigue, G
The SCALE trial (2013) was the first document on how effective a GLP-1 (Liraglutide) can be when combined with lifestyle changes
Fish-odour syndrome and impaired n-oxidation
That origin is what makes the modern lie so effective: among social media posts that mention skin cancer at all, more than a third claim melanotan actually protects against it, some pitched explicitly as a sunscreen alternative